Dr. Douglas Robert Schulte, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 888 Main St, Wakefield, MA 01880 Phone: 781-620-4888 Fax: 781-245-2602 |
Dr. David A Calef, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 33 Avon St, Wakefield, MA 01880 Phone: 781-245-0402 Fax: 781-246-0847 |
John Graydon Kidd, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 33 Avon St, Wakefield, MA 01880 Phone: 781-245-0402 |
Emily Chin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Edgewater Dr Ste 420, Wakefield, MA 01880 Phone: 781-901-0929 |
Benjamin Calef, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 33 Avon St, Wakefield, MA 01880 Phone: 781-245-0402 Fax: 781-246-0847 |
News Archive
An enzyme researchers have studied for years because of its potential connections to cancer, diabetes, heart disease, hypertension and stroke, appears to have yet another major role to play: helping create and maintain the brain.
Winola Lake has partnered with STAT Ticket, a Boston, Massachusetts based software company, to provide a unique hospital issue reporting system.
Researchers have pinpointed the specific part of the brain that older adults rely on to differentiate speech sounds in background noise, which could revolutionize the treatment of hearing loss.
Orlando-based nutraceutical company XYMOGEN has announced a 2013-2014 seminar series, The Metabolic Nexus. The event series, which features presentations from healthcare industry pioneers, aims to bridge the knowledge gap between patients and healthcare professionals.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
› Verified 2 days ago